NCT06650943

Brief Summary

The goal of this clinical trial is to evaluate if a nursing intervention based on the carbohydrate-insulin model can effectively reduce weight and manage the risk of metabolic syndrome (MetS) in individuals with first-episode psychosis. The main questions it aims to answer are: Will the intervention lead to a clinically significant weight loss (≥5%)? Can the intervention improve metabolic parameters, psychopathological state, physical activity level, and quality of life? Researchers will compare participants receiving the specialized nursing consultations to those receiving routine care to see if the former group experiences greater improvements in weight loss and metabolic risk reduction. Participants will: Attend a series of 8 nursing consultations focused on dietary habits based on the carbohydrate-insulin model and physical activity. Complete assessments at the start, 6 months, and 12 months, including weight, metabolic parameters, and psychological evaluations.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Oct 2023Jun 2026

Study Start

First participant enrolled

October 25, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

October 18, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 21, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

October 22, 2024

Status Verified

October 1, 2024

Enrollment Period

2.7 years

First QC Date

October 18, 2024

Last Update Submit

October 20, 2024

Conditions

Keywords

FEPpsychosismetabolic syndromenursingmental health nurse

Outcome Measures

Primary Outcomes (1)

  • Weight

    Weight in kilograms

    From enrollment to the end of treatment at 48 weeks

Secondary Outcomes (5)

  • Metabolic Syndrome

    From enrollment to the end of treatment at 48 weeks

  • Psychopathology

    From enrollment to the end of treatment at 48 weeks

  • Depressive symptoms

    From enrollment to the end of treatment at 48 weeks

  • Qualit of Life

    From enrollment to the end of treatment at 48 weeks

  • Reported phisical activity

    From enrollment to the end of treatment at 48 weeks

Study Arms (2)

Intervention

EXPERIMENTAL

The intervention consists of 8 nursing consultations with a mental health nurse trained in healthy habits for individuals with psychosis. During the first 2 months, 4 consultations will focus on dietary habits based on the carbohydrate-insulin theory and physical activity, following a guide developed by experts, incorporating recommendations from the American Diabetes Association. Visits 5 and 6 occur at 3 and 4 months; visit 7 at 6 months to evaluate effectiveness, and visit 8 at 12 months. Weight will be monitored throughout. Assessments at baseline, 6, and 12 months will include labs, vital signs, and scales for psychopathology, quality of life, and activity level. Each session covers key topics, from intervention goals to diet tips and physical activity. The approach is flexible, aiming for gradual habit integration, supported by a therapeutic relationship. Phone reminders will enhance adherence.

Behavioral: Nursing Consultation in Weight Management and Metabolic syndrome

Control

NO INTERVENTION

Ccontrol group will continue their usual follow-up within the EIP, attending consultations with their reference psychiatrist and receiving pharmacological or psychotherapeutic treatment as they did before the intervention. The control group will not receive any specific nursing consultations (beyond the administration of long-acting injectable antipsychotics where appropriate) or dietary or lifestyle advice during the follow-up. If patients in the control group require treatment or assistance for metabolic problems, they will be referred to primary care or endocrinology professionals, as was done previous to the intervention implementation.

Interventions

Based on the Carbohydrate-insulin Theory

Intervention

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients admitted to the Early Intervention Program (EIP).
  • First-episode psychosis (FEP) within the last 5 years.
  • Diagnosis of psychosis from the F2 spectrum or an affective disorder with psychotic symptoms according to ICD-10.

You may not qualify if:

  • Cognitive inability to learn or comorbid intellectual disability that interferes with study procedures.
  • Comorbid diagnosis of neurological pathology.
  • Language or comprehension impairments preventing accurate data collection.
  • Use of hypoglycemic medication before or during the study.
  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Basurto

Bilbao, Vizcaya, 48013, Spain

RECRUITING

Related Publications (1)

  • Madaria L, Aymerich C, Catalan A, Gonzalez-Torres MA. Protocol of an Efficacy Study on Nursing Consultation in Weight Management and Metabolic Syndrome Based on the Carbohydrate-Insulin Theory in Individuals with First-Episode Psychosis. Nurs Rep. 2024 Dec 27;15(1):3. doi: 10.3390/nursrep15010003.

MeSH Terms

Conditions

Metabolic SyndromePsychotic Disorders

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesSchizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The psychometric scale evaluators will be blinded.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Mental Health Nurse Specialist

Study Record Dates

First Submitted

October 18, 2024

First Posted

October 21, 2024

Study Start

October 25, 2023

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

October 22, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations